| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| NRCNational Research Corporation | 482.6M | 21.30 | 20.48 | -3.72% | 11.76% | 114.31% | 3.97% | 2.06 |
| WORXSCWorx Corp. | 2.91M | 0.18 | -0.24 | -21.43% | -139.71% | -64.87% | 0.01 | |
| DHDefinitive Healthcare Corp. | 251.03M | 2.43 | -0.69 | 0.31% | -77.88% | -48.42% | 18.27% | 0.42 |
| HCATHealth Catalyst, Inc. | 165.51M | 2.34 | -2.03 | 3.6% | -34.05% | -32.42% | 1.10 | |
| ZCMDZhongchao Inc. | 12.21M | 0.47 | -3.95 | -18.37% | -26.94% | -34.62% | 0.00 | |
| EVHEvolent Health, Inc. | 439.71M | 3.94 | -4.86 | 30.09% | -6.24% | -15.22% | 0.71 | |
| FORAForian Inc. | 66.18M | 2.13 | -17.75 | -1.6% | -3.03% | -2.74% | 0.43% | 0.22 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Sales/Revenue | 85.5M | 118.32M | 166.15M | 222.65M | 251.41M | 252.2M |
| Revenue Growth % | - | 0.38% | 0.4% | 0.34% | 0.13% | 0% |
| Cost of Goods Sold | 43.04M | 30.47M | 40.69M | 42.63M | 47.48M | 54.73M |
| COGS % of Revenue | 0.5% | 0.26% | 0.24% | 0.19% | 0.19% | 0.22% |
| Gross Profit | 42.47M | 87.85M | 125.47M | 180.03M | 203.93M | 197.47M |
| Gross Margin % | 0.5% | 0.74% | 0.76% | 0.81% | 0.81% | 0.78% |
| Gross Profit Growth % | - | 1.07% | 0.43% | 0.43% | 0.13% | -0.03% |
| Operating Expenses | 44.64M | 103.73M | 152.78M | 224.07M | 533.73M | 908.29M |
| OpEx % of Revenue | 0.52% | 0.88% | 0.92% | 1.01% | 2.12% | 3.6% |
| Selling, General & Admin | 37.2M | 48.7M | 89.25M | 141.15M | 153.4M | 133.07M |
| SG&A % of Revenue | 0.44% | 0.41% | 0.54% | 0.63% | 0.61% | 0.53% |
| Research & Development | 7.45M | 11.06M | 18.57M | 34.89M | 42.44M | 36.52M |
| R&D % of Revenue | 0.09% | 0.09% | 0.11% | 0.16% | 0.17% | 0.14% |
| Other Operating Expenses | 0 | 43.97M | 44.97M | 48.03M | 337.9M | 738.7M |
| Operating Income | -2.17M | -15.89M | -27.32M | -44.04M | -329.8M | -710.82M |
| Operating Margin % | -0.03% | -0.13% | -0.16% | -0.2% | -1.31% | -2.82% |
| Operating Income Growth % | - | -6.3% | -0.72% | -0.61% | -6.49% | -1.16% |
| EBITDA | 31.36M | 43.7M | 32.63M | 12.86M | -278.05M | -659.15M |
| EBITDA Margin % | 0.37% | 0.37% | 0.2% | 0.06% | -1.11% | -2.61% |
| EBITDA Growth % | - | 0.39% | -0.25% | -0.61% | -22.62% | -1.37% |
| D&A (Non-Cash Add-back) | 33.54M | 59.58M | 59.95M | 56.9M | 51.75M | 51.67M |
| EBIT | -18.03M | -16.11M | -36.87M | -30.68M | -292.98M | -618.91M |
| Net Interest Income | 0 | -36.49M | -25.87M | -8.41M | -1.56M | -245K |
| Interest Income | 18.37M | 0 | 29K | 2.79M | 13.64M | 14.59M |
| Interest Expense | 18.37M | 36.49M | 25.9M | 11.2M | 15.2M | 14.84M |
| Other Income/Expense | -34.22M | -36.71M | -35.45M | 2.17M | 21.62M | 77.08M |
| Pretax Income | -36.4M | -52.6M | -62.77M | -41.88M | -308.18M | -633.75M |
| Pretax Margin % | -0.43% | -0.44% | -0.38% | -0.19% | -1.23% | -2.51% |
| Income Tax | 0 | 0 | -443K | -17.7M | -18.55M | -42.3M |
| Effective Tax Rate % | 1% | 1% | 0.83% | 0.17% | 0.66% | 0.65% |
| Net Income | -36.4M | -52.6M | -51.91M | -7.22M | -202.39M | -413.12M |
| Net Margin % | -0.43% | -0.44% | -0.31% | -0.03% | -0.8% | -1.64% |
| Net Income Growth % | - | -0.45% | 0.01% | 0.86% | -27.02% | -1.04% |
| Net Income (Continuing) | -36.4M | -52.6M | -62.32M | -24.18M | -289.63M | -591.45M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 628.52M | 533.03M | 337.82M | 162.82M |
| EPS (Diluted) | -0.24 | -0.53 | -0.19 | -0.07 | -1.79 | -3.54 |
| EPS Growth % | - | -1.21% | 0.64% | 0.62% | -24.07% | -0.98% |
| EPS (Basic) | -0.24 | -0.53 | -0.19 | -0.07 | -1.79 | -3.54 |
| Diluted Shares Outstanding | 149.1M | 97.03M | 97.03M | 101.11M | 112.76M | 116.64M |
| Basic Shares Outstanding | 149.1M | 97.03M | 97.03M | 101.11M | 112.76M | 116.64M |
| Dividend Payout Ratio | - | - | - | - | - | - |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Total Current Assets | 36.11M | 63.84M | 444.23M | 413.75M | 380.44M | 370.17M |
| Cash & Short-Term Investments | 8.62M | 24.77M | 387.5M | 331.87M | 308.07M | 290.16M |
| Cash Only | 8.62M | 24.77M | 387.5M | 146.93M | 130.98M | 105.38M |
| Short-Term Investments | 0 | 0 | 0 | 184.94M | 177.09M | 184.79M |
| Accounts Receivable | 25.02M | 33.11M | 43.34M | 58.8M | 59.25M | 53.23M |
| Days Sales Outstanding | 106.81 | 102.14 | 95.2 | 96.39 | 86.02 | 77.04 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - |
| Other Current Assets | 769K | 2.95M | 6.88M | 23.07M | 13.12M | 26.78M |
| Total Non-Current Assets | 1.69B | 1.68B | 1.67B | 1.71B | 1.43B | 719.22M |
| Property, Plant & Equipment | 2.56M | 3.25M | 5.07M | 14.14M | 14.06M | 11.31M |
| Fixed Asset Turnover | 33.43x | 36.43x | 32.78x | 15.74x | 17.88x | 22.30x |
| Goodwill | 1.23B | 1.26B | 1.26B | 1.32B | 1.08B | 393.28M |
| Intangible Assets | 446.38M | 410.24M | 352.47M | 350.72M | 323.12M | 297.93M |
| Long-Term Investments | 0 | 5.95M | 32.67M | 0 | 509K | 0 |
| Other Non-Current Assets | 2.72M | 472K | 19.94M | 19.28M | 19.2M | 16.69M |
| Total Assets | 1.72B | 1.75B | 2.12B | 2.12B | 1.83B | 1.09B |
| Asset Turnover | 0.05x | 0.07x | 0.08x | 0.10x | 0.14x | 0.23x |
| Asset Growth % | - | 0.01% | 0.21% | 0% | -0.14% | -0.4% |
| Total Current Liabilities | 69.92M | 88.72M | 123.12M | 140.61M | 170.68M | 161.16M |
| Accounts Payable | 2.16M | 5.66M | 4.65M | 3.95M | 5.79M | 10.76M |
| Days Payables Outstanding | 18.29 | 67.83 | 41.72 | 33.81 | 44.49 | 71.78 |
| Short-Term Debt | 4.5M | 4.68M | 6.88M | 8.59M | 13.75M | 13.75M |
| Deferred Revenue (Current) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 338K | 2.08M | 2.97M | 3.16M | 38.72M | 25.21M |
| Current Ratio | 0.52x | 0.72x | 3.61x | 2.94x | 2.23x | 2.30x |
| Quick Ratio | 0.52x | 0.72x | 3.61x | 2.94x | 2.23x | 2.30x |
| Cash Conversion Cycle | - | - | - | - | - | - |
| Total Non-Current Liabilities | 435M | 461.07M | 494.66M | 500.07M | 456.05M | 321.03M |
| Long-Term Debt | 434.85M | 457.2M | 263.81M | 255.76M | 242.57M | 229.37M |
| Capital Lease Obligations | 0 | 0 | 0 | 9.97M | 9.37M | 7.59M |
| Deferred Tax Liabilities | 0 | 0 | 76.4M | 75.74M | 67.16M | 25.09M |
| Other Non-Current Liabilities | 0 | 3.74M | 154.04M | 158.36M | 136.93M | 58.96M |
| Total Liabilities | 504.91M | 549.8M | 617.78M | 640.68M | 626.73M | 482.19M |
| Total Debt | 439.35M | 461.88M | 270.68M | 275.85M | 267.93M | 253.11M |
| Net Debt | 430.73M | 437.1M | -116.81M | 128.91M | 136.95M | 147.73M |
| Debt / Equity | 0.36x | 0.39x | 0.18x | 0.19x | 0.22x | 0.42x |
| Debt / EBITDA | 14.01x | 10.57x | 8.30x | 21.45x | - | - |
| Net Debt / EBITDA | 13.73x | 10.00x | -3.58x | 10.02x | - | - |
| Interest Coverage | -0.12x | -0.44x | -1.05x | -3.93x | -21.69x | -47.91x |
| Total Equity | 1.22B | 1.2B | 1.5B | 1.48B | 1.2B | 607.19M |
| Equity Growth % | - | -0.02% | 0.25% | -0.01% | -0.19% | -0.49% |
| Book Value per Share | 8.16 | 12.32 | 15.46 | 14.66 | 10.63 | 5.21 |
| Total Shareholders' Equity | 1.22B | 1.2B | 871.31M | 948.92M | 861.36M | 444.38M |
| Common Stock | 1.27B | 1.31B | 97K | 105K | 117K | 114K |
| Retained Earnings | -55.76M | -109.86M | -17.84M | -25.06M | -227.45M | -640.57M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | -131K | 62K | 3.67M | 2.11M | -610K |
| Minority Interest | 0 | 0 | 628.52M | 533.03M | 337.82M | 162.82M |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Cash from Operations | 21.59M | 23.22M | 25.21M | 35.58M | 41.19M | 58.2M |
| Operating CF Margin % | 0.25% | 0.2% | 0.15% | 0.16% | 0.16% | 0.23% |
| Operating CF Growth % | - | 0.08% | 0.09% | 0.41% | 0.16% | 0.41% |
| Net Income | -36.4M | -52.6M | -62.32M | -22.25M | -202.39M | -591.45M |
| Depreciation & Amortization | 33.54M | 59.58M | 59.95M | 56.9M | 51.75M | 51.67M |
| Stock-Based Compensation | 0 | 1.75M | 9.96M | 36.43M | 48.74M | 38.09M |
| Deferred Taxes | 0 | 0 | -587K | -26.67M | -18.71M | -119.58M |
| Other Non-Cash Items | 12.02M | 14.63M | 20.73M | 13.12M | 192.19M | 705.4M |
| Working Capital Changes | 12.43M | -147K | -2.51M | -21.95M | -30.39M | -25.93M |
| Change in Receivables | -8.62M | -8.29M | -10.73M | -13.22M | 811K | 5.69M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 7.95M | 4.44M | 3.42M | 358K | 1.33M | -5.46M |
| Cash from Investing | -1.14B | -23.86M | -46.73M | -248.9M | -31.78M | -26.41M |
| Capital Expenditures | -1.9M | -1.4M | -6.73M | -8.33M | -2.98M | -12.34M |
| CapEx % of Revenue | 0.02% | 0.01% | 0.04% | 0.04% | 0.01% | 0.05% |
| Acquisitions | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 1.12B | 16.66M | 384.37M | -26.7M | -25.58M | -56.75M |
| Debt Issued (Net) | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - |
| Dividends Paid | -6.96M | -2.94M | -8.13M | -12.87M | -12.28M | -5.13M |
| Share Repurchases | - | - | - | - | - | - |
| Other Financing | 0 | 6.14M | -11.22M | -5.22M | -4.68M | -15.5M |
| Net Change in Cash | - | - | - | - | - | - |
| Free Cash Flow | 19.69M | 21.82M | 18.48M | 27.25M | 38.21M | 45.85M |
| FCF Margin % | 0.23% | 0.18% | 0.11% | 0.12% | 0.15% | 0.18% |
| FCF Growth % | - | 0.11% | -0.15% | 0.47% | 0.4% | 0.2% |
| FCF per Share | 0.13 | 0.22 | 0.19 | 0.27 | 0.34 | 0.39 |
| FCF Conversion (FCF/Net Income) | -0.59x | -0.44x | -0.49x | -4.93x | -0.20x | -0.14x |
| Interest Paid | 0 | 25.96M | 29.57M | 0 | 14.46M | 0 |
| Taxes Paid | 0 | 0 | 13K | 0 | 136K | 0 |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -2.99% | -4.36% | -3.85% | -0.48% | -15.1% | -45.74% |
| Return on Invested Capital (ROIC) | - | -0.73% | -1.36% | -2.21% | -16.79% | -50.99% |
| Gross Margin | 49.67% | 74.25% | 75.51% | 80.86% | 81.11% | 78.3% |
| Net Margin | -42.57% | -44.46% | -31.24% | -3.24% | -80.5% | -163.81% |
| Debt / Equity | 0.36x | 0.39x | 0.18x | 0.19x | 0.22x | 0.42x |
| Interest Coverage | -0.12x | -0.44x | -1.05x | -3.93x | -21.69x | -47.91x |
| FCF Conversion | -0.59x | -0.44x | -0.49x | -4.93x | -0.20x | -0.14x |
| Revenue Growth | - | 38.38% | 40.43% | 34% | 12.92% | 0.31% |
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Subscription Services | - | 217.02M | 243.05M | 244.89M |
| Subscription Services Growth | - | - | 11.99% | 0.75% |
| Professional Services | 1.59M | 5.63M | 8.36M | 7.32M |
| Professional Services Growth | - | 254.03% | 48.57% | -12.52% |
| Platform Subscriptions | 164.56M | - | - | - |
| Platform Subscriptions Growth | - | - | - | - |
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| UNITED STATES | 158.73M | 211.73M | 239.46M | 241.81M |
| UNITED STATES Growth | - | 33.39% | 13.10% | 0.98% |
| Non-US | - | 10.93M | 11.96M | 10.4M |
| Non-US Growth | - | - | 9.45% | -13.05% |
| Non Us | 7.43M | - | - | - |
| Non Us Growth | - | - | - | - |
Definitive Healthcare Corp. (DH) reported $242.3M in revenue for fiscal year 2024. This represents a 183% increase from $85.5M in 2019.
Definitive Healthcare Corp. (DH) grew revenue by 0.3% over the past year. Growth has been modest.
Definitive Healthcare Corp. (DH) reported a net loss of $188.7M for fiscal year 2024.
Yes, Definitive Healthcare Corp. (DH) pays a dividend with a yield of 1.81%. This makes it attractive for income-focused investors.
Definitive Healthcare Corp. (DH) has a return on equity (ROE) of -45.7%. Negative ROE indicates the company is unprofitable.
Definitive Healthcare Corp. (DH) generated $46.0M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.